Results 191 to 200 of about 133,418 (255)
Living Hydrogels: Harnessing Microorganism–Material Synergy for Next‐Generation Therapeutics
Advanced Science, Volume 13, Issue 25, 4 May 2026.. ABSTRACT Microorganism‐based therapies, particularly those utilizing probiotics, have emerged as a powerful biomedical strategy owing to their inherent living functionalities. These living systems can dynamically interact with host environments and self‐regulate their activity, offering superior adaptability, prolonged functionality, and ...
Shuifang Mao +3 more
wiley +1 more source
Not Only Enteropathy: The Overlooked “Gastric Side” of Olmesartan
Clinical Case Reports, Volume 14, Issue 5, May 2026.ABSTRACT Several medications can be associated with gastrointestinal adverse effects. Olmesartan has been linked to a broad spectrum of gastrointestinal injuries. Although sprue‐like enteropathy is well known, less common involvements such as gastropathy can be equally debilitating.
Cecilia Lina Pugliano +5 more
wiley +1 more source
When Carcinoma Meets Sarcoma: A Rare Case of Pancreatic Carcinosarcoma and Review of Literature
Clinical Case Reports, Volume 14, Issue 5, May 2026.ABSTRACT Pancreatic carcinosarcoma is an extremely rare and aggressive malignancy with both epithelial and mesenchymal components. This case contributes to the limited global literature, emphasizing the importance of awareness, accurate diagnosis, and further research to improve understanding and management of this lethal tumor.
Pouria Abedini +4 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 5, May 2026.ABSTRACT Eosinophilic esophagitis (EoE) is a chronic, immune‐mediated disease requiring long‐term therapy. Dupilumab, an interleukin‐4 and interleukin‐13 receptor antagonist, is approved for EoE at a weekly 300 mg dosing regimen. However, data on reduced‐frequency dosing, especially in pediatric patients, remain limited.
Giovanni Scatigna +4 more
wiley +1 more source
Spondyloarthritis Associated With Collagenous Colitis—Case Report and Literature Review
Clinical Case Reports, Volume 14, Issue 5, May 2026.ABSTRACT Collagenous colitis (CC) is a subtype of microscopic colitis characterized by chronic watery diarrhea with normal endoscopic findings. Although often linked to autoimmune diseases, its association with spondyloarthropathy (SpA) is rare and poorly documented.
Charlotte Bouvy +4 more
wiley +1 more source
Advanced Gastric Cancer Presenting as a Giant Subepithelial Lesion: A Case Report
Clinical Case Reports, Volume 14, Issue 5, May 2026.A giant subepithelial lesion. ABSTRACT Gastric cancer may occasionally present with a subepithelial lesion‐like appearance. When a gastric gastrointestinal stromal tumor (GIST) is suspected preoperatively without definitive pathological confirmation, intraoperative frozen section analysis is recommended to prevent inappropriate surgical intervention.
Ji Sun +6 more
wiley +1 more source
Pernicious Anemia and Helicobacter pylori Infection: What a Hematologist Needs to Know?
Clinical Case Reports, Volume 14, Issue 5, May 2026.Helicobacter pylori infection and the possible underlying mechanism of parietal cell damage, and progression to pernicious anemia. ABSTRACT This case report emphasizes the importance of early detection and prompt treatment of Helicobacter pylori (H. pylori) as a reversible cause of autoimmune gastritis and its associated vitamin B‐12 deficiency.
Eisha Saadat +2 more
wiley +1 more source
Gastric Cancer Literacy and Related Factors in Iran: A Cross‐Sectional Study
Cancer Reports, Volume 9, Issue 5, May 2026.ABSTRACT Background Gastric cancer (GC) is one of the most prevalent and deadly cancers worldwide, particularly in countries like Iran. Gastric cancer health literacy (GCHL) plays a key role in early detection, prevention, and timely treatment. This study aims to investigate the level of GCHL and its associated factors among adults in Torbat Heydarieh,
Fatemeh Pourhaji +2 more
wiley +1 more source
Gut Microbiota: A Potential Role in Modulating Carcinogenesis and Response to Anti‐Cancer Therapies
Cancer Reports, Volume 9, Issue 5, May 2026.ABSTRACT Background The effects of microbiota on cancer are not only limited to their role in oncogenesis, progression and response to anticancer therapies; the disease itself is also influenced by microbiota. In recent investigations, alterations in the gut bacterial community between cancer patients and healthy individuals have been reported ...
Awgichew Shewasinad Yehualashet +3 more
wiley +1 more source